CRISPR/Cas9-related technologies in liver diseases: from feasibility to future diversity

Authors: Tao Xu, Li Li, Yu-chen Liu, Wei Cao, Jia-si Chen, Shuang Hu, Ying Liu, Liang-yun Li, Hong Zhou, Xiao-ming Meng, Cheng Huang, Lei Zhang, Jun Li, Huan Zhou

Published: 2020-06-15

DOI: 10.7150/ijbs.33481

Source: Full article

---

Abstract

No abstract found.